Click to copy
https://factapalooza.com/en/query-87
Compare confirmed fatalities from ivermectin use to fatalities from other commonly prescribed drugs.
Type
Text → Text
Topic
When comparing confirmed fatalities from ivermectin use to those from other commonly prescribed medications, there are some important distinctions to note:
Ivermectin:
- Ivermectin has an exceptionally strong safety profile when used as directed
- Serious adverse events and fatalities are extremely rare when used at standard doses for approved indications
- The WHO reports that billions of doses have been administered globally with very few serious adverse events
- Most confirmed fatalities have involved:
- Accidental massive overdoses
- Use of veterinary formulations not intended for humans
- Interaction with other medications in patients with severe comorbidities
Common medications with higher fatality rates:
- NSAIDs (ibuprofen, naproxen, etc.):
- Cause approximately 7,000-16,000 deaths annually in the US due to gastrointestinal bleeding
- Associated with increased cardiovascular events
- Opioid Pain Medications:
- Responsible for tens of thousands of overdose deaths annually
- In 2019 alone, nearly 50,000 people died from opioid-involved overdoses in the US
- Acetaminophen/Paracetamol:
- Leading cause of acute liver failure in many countries
- Several hundred deaths annually in the US alone from accidental overdose
- Warfarin and other anticoagulants:
- Associated with thousands of emergency department visits annually due to bleeding events
- Significant mortality risk if not properly monitored
- Digoxin:
- Narrow therapeutic window
- Several hundred deaths annually from toxicity
It's important to note that these comparisons should be contextualized by:
- The number of prescriptions written (exposure rate)
- The conditions being treated (risk-benefit profile)
- Patient populations receiving the medications
- Monitoring practices
In summary, when used as directed for approved indications, ivermectin has one of the better safety profiles among commonly prescribed medications, with extremely low rates of serious adverse events or fatalities compared to many everyday medications.
Confirmed fatalities from ivermectin use are relatively rare when the drug is used as prescribed for approved conditions. However, misuse during the COVID-19 pandemic, such as taking veterinary formulations or excessive doses, led to poisonings and some fatalities.
In contrast, other commonly prescribed drugs have higher associated fatality rates:
- Opioids: Thousands of fatalities annually due to overdose, making them a leading cause of drug-related deaths.
- Anticoagulants: Drugs like warfarin can cause fatal bleeding events if not carefully monitored.
- Benzodiazepines: Overdose or misuse, especially in combination with other substances, can result in fatalities.
While ivermectin has a relatively low risk of fatality when used correctly, the misuse of any medication can lead to serious consequences. Let me know if you'd like further details or comparisons!
Core Finding: When used as prescribed for approved conditions, ivermectin demonstrates significantly lower fatality rates than many commonly prescribed medications. Most ivermectin-related deaths occur with off-label use, overdose, or veterinary formulations.
Reported Fatalities per Million Prescriptions
| Medication | Primary Use | Estimated Fatalities/Million Rx | Risk Context |
|---|---|---|---|
| Ivermectin (human use) | Antiparasitic | 0.1-0.3 | Nearly all from Loa loa coinfection complications |
| Acetaminophen (Paracetamol) | Pain reliever | 6-8 | Liver toxicity from overdose |
| Warfarin | Anticoagulant | 30-50 | Bleeding complications |
| Insulin | Diabetes | 15-20 | Hypoglycemia events |
| Opioids (e.g., Oxycodone) | Pain management | 80-120 | Respiratory depression |
| Chemotherapy agents | Cancer treatment | 500-1,000+ | Therapeutic toxicity |
Data sources: WHO pharmacovigilance databases, FDA Adverse Event Reporting System (FAERS), and peer-reviewed studies (2010-2020 data)
Key Safety Comparisons
| Safety Aspect | Ivermectin | Average Common Drug |
|---|---|---|
| Therapeutic index (safety margin) | Very high (~100:1) | Variable (often 10:1 or less) |
| Overdose fatalities (human formulations) | Extremely rare | Leading cause of ER visits |
| Drug-drug interactions | Few significant interactions | Often numerous |
| Chronic use risks | Minimal (used as single dose in most cases) | Cumulative toxicity common |
Critical Note: 97% of ivermectin-related fatalities reported to US poison centers (1999-2020) involved:
- Ingestion of veterinary formulations (high-dose concentrates)
- COVID-19 self-treatment without medical supervision
- Pre-existing Loa loa infection (risk of encephalopathy)
Global Perspective
- Africa: 3-5 reported deaths/year among ~300 million annual doses (mostly Loa loa related)
- United States: 2-3 deaths/year pre-2020 (all from veterinary product misuse)
- EU: Zero confirmed deaths from proper medical use in past decade
While pinpointing the exact number of confirmed fatalities solely due to ivermectin use is challenging due to varying reporting standards, the availability of detailed individual case reports, and the potential for confounding factors, here's a comparison based on available information:
Fatalities Potentially Linked to Ivermectin:
- Overdose and Misuse: The FDA and poison control centers have reported cases of hospitalizations and adverse events, including neurological issues, seizures, coma, and even death, associated with ivermectin overdose, particularly when using formulations intended for animals or taking excessively high doses.
- Interaction with other medications: Ivermectin can interact with blood thinners, increasing the risk of bleeding, which could potentially be fatal in some circumstances.
- Mazzotti reaction: In patients treated for river blindness, ivermectin can cause a severe reaction (Mazzotti reaction) with symptoms like fever, itching, swollen lymph nodes, and in rare cases, more severe complications.
- Lack of widespread reporting of direct fatalities: Despite the concerns and warnings, especially during the COVID-19 pandemic when its use surged, there hasn't been a large number of confirmed deaths directly attributed solely to correctly prescribed ivermectin for its approved uses. Most severe adverse events and fatalities reported seem to be linked to misuse, overdose, or use of veterinary formulations.
Fatalities from Other Commonly Prescribed Drugs:
It's crucial to understand that many commonly prescribed drugs carry risks of serious adverse events, including fatalities. Here are some examples:
- Opioid Painkillers: These are a leading cause of drug overdose deaths in the United States. In 2022, over 80,000 overdose deaths involved opioids. Prescription opioids were involved in over 14,000 of these deaths. Overdose can cause respiratory depression, leading to hypoxia, coma, and death.
- Benzodiazepines: Commonly prescribed for anxiety and insomnia, benzodiazepines can cause respiratory depression, especially when taken in high doses or combined with other central nervous system depressants like opioids or alcohol. Over 10,000 overdose deaths involved benzodiazepines in 2022.
- Antidepressants: While generally considered safer in overdose than older antidepressants, they can still be fatal, especially when mixed with other drugs. In 2022, over 5,800 overdose deaths involved antidepressants.
- Acetaminophen (Paracetamol): A common over-the-counter pain reliever, acetaminophen overdose is a leading cause of acute liver failure and can be fatal. It's estimated to cause around 450 deaths annually in the U.S., with about 100 being unintentional.
- Warfarin: A commonly prescribed blood thinner, warfarin increases the risk of bleeding. While it doesn't typically cause immediate overdose deaths, severe bleeding events due to interactions or incorrect dosing can be fatal.
- Insulin: Incorrect dosing of insulin, a crucial medication for diabetes, can lead to severe hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), both of which can be fatal if not treated promptly.
Key Differences and Considerations:
- Scale of Use: Drugs like opioids, benzodiazepines, antidepressants, and acetaminophen are prescribed and used on a far wider scale than ivermectin, even before the COVID-19 pandemic. Higher usage naturally leads to a greater number of reported adverse events, including fatalities.
- Mechanism of Toxicity: Many common drugs have well-established mechanisms of overdose toxicity (e.g., respiratory depression with opioids and benzodiazepines, liver failure with acetaminophen). For ivermectin, fatalities seem more linked to massive overdoses causing neurological and cardiovascular issues or severe allergic reactions.
- Context of Fatality: Fatalities associated with commonly prescribed drugs often involve intentional overdose, accidental overdose due to dosage errors or drug interactions, or severe adverse reactions at therapeutic doses. For ivermectin, many of the reported severe events are linked to off-label use for COVID-19 and the use of veterinary formulations.
- Data Limitations: Precise data on fatalities directly caused by any single medication can be challenging to obtain due to reporting biases, co-existing health conditions, and polypharmacy (the use of multiple drugs).
Conclusion:
While ivermectin can cause serious adverse effects and potentially lead to fatalities, particularly in cases of overdose or misuse, the number of confirmed deaths directly and solely attributed to its use at recommended doses for approved indications appears to be significantly lower than the fatalities associated with many other commonly prescribed drugs like opioids, benzodiazepines, and even acetaminophen, simply due to the much wider use and known risks associated with these medications. However, any medication can be harmful if misused, and ivermectin is no exception, as highlighted by reports of severe adverse events linked to its unapproved uses.
Fatalities from Ivermectin Use (Pre-2020 and Pandemic-Era Data)
- Confirmed fatalities from properly prescribed human ivermectin were very rare.
- When ivermectin was used at correct doses for approved uses, reports of death were exceptionally uncommon.
- However, when people self-medicated with veterinary formulations (especially during the COVID-19 pandemic), or massively overdosed, there were some documented cases of serious toxicity and a few fatalities.
- In official toxicology databases (like Poison Control Centers), deaths directly attributed to ivermectin were extremely low — typically a handful over several years worldwide.
- Example:
The U.S. National Poison Data System (NPDS) report from 2021 noted a spike in ivermectin exposures, but actual deaths were very rare — possibly 1–2 deaths among thousands of poisonings.
Fatalities from Other Commonly Prescribed Drugs
| Drug | Typical Use | Fatalities/Overdose Risk |
|---|---|---|
| Opioids (e.g., oxycodone, hydrocodone) | Pain management | Tens of thousands of deaths per year (U.S.). Huge crisis (opioid epidemic). |
| Benzodiazepines (e.g., Xanax, Valium) | Anxiety, sleep | Thousands of deaths annually, often in combination with other drugs. |
| Acetaminophen (Tylenol) | Pain, fever | Leading cause of acute liver failure; hundreds of deaths annually from overdose. |
| SSRIs (e.g., Prozac, Zoloft) | Depression, anxiety | Overdose deaths are relatively rare, but still occur (especially in combination with other substances). |
| Warfarin | Blood thinner (prevent stroke) | Significant risk of fatal bleeding if improperly dosed; hundreds of deaths annually (though harder to separate from patient underlying conditions). |
| Ibuprofen (Advil) | Pain, inflammation | Deaths are rare but occur with massive overdose or chronic misuse (kidney, gastrointestinal damage). |
Summary
- Ivermectin, when used correctly for its approved medical uses, has historically had very low fatality rates compared to almost any other commonly prescribed drug.
- Drugs like opioids, benzodiazepines, and even over-the-counter drugs like acetaminophen have far higher death rates.
- However:
- When ivermectin is misused (wrong formulations, massive overdoses), it can be fatal.
- Self-medication with veterinary ivermectin or megadoses during COVID-19 introduced new risks that didn’t exist before.
Bottom Line:
✅ Ivermectin has a strong safety profile in approved uses.
⚠️ Most drug-related deaths involve much more commonly prescribed medications — not ivermectin.
Comparing confirmed fatalities from ivermectin to other commonly prescribed drugs is challenging due to limited data on drug-specific mortality, under-reporting in pharmacovigilance systems, and differences in usage contexts (e.g., approved vs. off-label use). Below is an analysis based on available evidence, focusing on ivermectin and commonly prescribed drugs like acetaminophen (Tylenol), ibuprofen, antibiotics (e.g., amoxicillin), and statins (e.g., atorvastatin). The comparison considers fatalities linked to approved uses and, where relevant, off-label uses like ivermectin for COVID-19.
Ivermectin Fatalities
- Approved Uses (Parasitic Infections): Ivermectin is generally safe for treating parasitic infections like onchocerciasis and strongyloidiasis at recommended doses (0.2 mg/kg). Fatalities are rare but occur, particularly in specific contexts:
- A 1997 study reported 15 deaths among 47 nursing home residents treated with ivermectin (0.2 mg/kg) for scabies, though causality was unclear and not definitively linked to the drug.
- In the Democratic Republic of Congo (2003–2017), 55 deaths were recorded among 945 severe adverse events (SAEs) during mass drug administration for onchocerciasis, yielding a 5.8% case-fatality rate among SAEs (6 cases per 100,000 treated annually). Most deaths were linked to loiasis co-infection, which can cause neurological complications with ivermectin.
- The WHO’s VigiBase (2003–2020) reported serious adverse reactions, including encephalopathies, but specific fatality counts for approved uses are low and often confounded by underlying conditions like loiasis.
- Off-Label Use (COVID-19): Increased use during the COVID-19 pandemic led to rare but documented fatalities:
- The WHO’s VigiBase (May 2020–December 2021) recorded 6 deaths among 1,777 serious cases where ivermectin was used for COVID-19, often involving overdoses or unapproved indications.
- In New Mexico (2021), 2 deaths were linked to ivermectin toxicity, primarily from veterinary formulations taken for COVID-19.
- The Oregon Poison Center (2021) noted no deaths among 21 ivermectin-related calls, but hospitalizations occurred due to toxic effects.
- Estimated Fatalities: Exact numbers are elusive, but X posts citing CDC and FDA data (1995–2023) claim ~15 deaths annually for ivermectin, though this lacks primary source verification and may include both approved and off-label uses. Fatalities are likely in the low dozens annually globally, with higher risks from misuse (e.g., veterinary products or overdoses).
Fatalities from Other Commonly Prescribed Drugs
- Acetaminophen (Tylenol):
- Primary Risk: Liver failure from overdose, intentional or accidental.
- Data: Acetaminophen is a leading cause of drug-related fatalities in the U.S., with ~458–500 deaths annually from liver failure due to overdoses. It causes over 56,000 ER visits yearly, with ~26,000 hospitalizations.
- Context: Fatalities often occur from exceeding the recommended dose (4,000 mg/day) or combining with alcohol. Approved use at recommended doses is safe, but misuse is common due to its over-the-counter availability.
- Comparison: Acetaminophen fatalities (~500/year) far exceed ivermectin’s (~15/year, if X post data is accurate), driven by its widespread use and overdose risk.
- Ibuprofen (Advil, Motrin):
- Primary Risk: Gastrointestinal bleeding, kidney injury, or cardiovascular events at high doses.
- Data: Exact fatality numbers are scarce, but ibuprofen contributes to ~3,000–7,000 deaths annually in the U.S. from NSAID-related gastrointestinal complications (e.g., ulcers, bleeding). Fatalities from overdose are rare but reported, with ~100–200 cases annually in poison control data.
- Context: Fatalities typically occur in elderly patients or those with pre-existing conditions (e.g., ulcers, kidney disease). Approved use is safe for most, but chronic or high-dose use increases risk.
- Comparison: Ibuprofen’s fatality rate is higher than ivermectin’s, primarily due to its broader use and chronic administration.
- Amoxicillin (Antibiotic):
- Primary Risk: Allergic reactions (e.g., anaphylaxis) or rare complications like liver injury.
- Data: Fatalities are extremely rare, with anaphylaxis causing ~1–2 deaths per million prescriptions. U.S. poison control data (2020) reported no deaths among ~2,000 amoxicillin-related calls. Globally, antibiotic-related deaths (including amoxicillin) are estimated at <100 annually from direct adverse effects.
- Context: Amoxicillin is one of the most prescribed antibiotics, with millions of prescriptions annually. Fatalities are minimal due to its favorable safety profile.
- Comparison: Amoxicillin has fewer fatalities than ivermectin, reflecting its safer profile even with widespread use.
- Atorvastatin (Lipitor, Statin):
- Primary Risk: Rare cases of rhabdomyolysis (muscle breakdown) or liver injury.
- Data: Fatalities are exceptionally rare, with <10 deaths annually in the U.S. linked to statins, based on FDA adverse event reports. Rhabdomyolysis occurs in ~1 per 100,000 patients, with a low mortality rate.
- Context: Statins are prescribed to millions for cholesterol management. Fatalities are minimal due to rigorous monitoring and low adverse event rates.
- Comparison: Atorvastatin has fewer fatalities than ivermectin, owing to its tightly regulated use and rare severe side effects.
Summary Comparison
| Drug | Estimated Annual Fatalities (U.S./Global) | Primary Cause of Fatalities | Usage Context |
|---|---|---|---|
| Ivermectin | ~15 (unverified, likely low dozens globally) | Overdose, loiasis complications, off-label misuse | Parasitic infections, off-label COVID-19 use |
| Acetaminophen | ~458–500 (U.S.), higher globally | Liver failure from overdose | Pain relief, fever (OTC) |
| Ibuprofen | ~3,000–7,000 (U.S., NSAID-related) | GI bleeding, kidney injury | Pain, inflammation (OTC/prescription) |
| Amoxicillin | <100 (global), ~1–2 per million prescriptions | Anaphylaxis, rare liver injury | Bacterial infections |
| Atorvastatin | <10 (U.S.), minimal globally | Rhabdomyolysis, liver injury | Cholesterol management |
Key Observations
- Ivermectin: Fatalities are rare for approved uses but increase with off-label misuse (e.g., COVID-19, veterinary formulations). Its fatality rate is low compared to acetaminophen and ibuprofen but higher than amoxicillin and atorvastatin.
- Acetaminophen and Ibuprofen: High fatality rates due to widespread availability, overuse, and overdose risks. Their over-the-counter status amplifies exposure compared to prescription-only ivermectin.
- Amoxicillin and Atorvastatin: Extremely low fatality rates, reflecting their safety profiles and controlled prescribing practices.
- Data Limitations: Pharmacovigilance data (e.g., VigiBase, FDA) under-reports fatalities, and ivermectin’s off-label use for COVID-19 complicates comparisons. X posts citing ~15 deaths/year for ivermectin are inconclusive without primary source validation.
- Context Matters: Ivermectin’s fatalities are often linked to specific conditions (e.g., loiasis) or misuse, while acetaminophen and ibuprofen fatalities stem from broader use patterns. Amoxicillin and atorvastatin benefit from safer profiles and stricter oversight.
Conclusion
Ivermectin’s confirmed fatalities are low (likely dozens annually, mostly from off-label use or specific parasitic co-infections) compared to acetaminophen (~500/year in the U.S.) and ibuprofen (~3,000–7,000/year from NSAIDs). However, it has a higher fatality rate than safer drugs like amoxicillin (<100 globally) and atorvastatin (<10 in the U.S.). Always consult a healthcare provider before using any medication, especially for unapproved indications like ivermectin for COVID-19, which carries risks of toxicity.
Here's a comparative analysis of fatalities associated with ivermectin versus other commonly prescribed drugs, based on available evidence:
Ivermectin-Related Fatalities
- COVID-19 misuse: 6 deaths reported in a 2022 study (May 2020-Dec 2021) among 35 serious cases where ivermectin was the sole suspect drug.
- Scabies treatment: 15 deaths reported in a 2005 Lancet study after combined treatment with ivermectin, lindane, and permethrin (specific contribution of ivermectin unclear).
- Overdose risks: Animal formulations and misuse led to neurotoxicity and hospitalizations, but exact fatality numbers remain limited in scope.
Comparison to Other Prescription Drugs
| Drug Category | Annual Fatalities (U.S.) | Key Risks |
|---|---|---|
| Opioids | ~50,000+ (2023 est.) | Respiratory depression, overdose |
| Benzodiazepines | Thousands (often combined with opioids) | Sedation, respiratory failure |
| Antidepressants | Part of ~17.6% of Rx overdose deaths | Serotonin syndrome, cardiac effects |
| NSAIDs | ~107,000 (annual est.) | GI bleeding, cardiovascular events |
| Antipsychotics | ~4-5 deaths/100 users/year (elderly) | Stroke, metabolic effects |
Key Observations
- Scale difference: Ivermectin's confirmed fatalities (dozens in studies) are orders of magnitude lower than opioids (50,000+/year) or NSAIDs (100,000+/year).
- Risk context:
- Ivermectin's primary risks involve off-label use (especially COVID-19) and veterinary formulation misuse.
- Common drugs like opioids and benzodiazepines show inherent risks even at prescribed doses.
- Mechanisms:
- Ivermectin fatalities involve neurological complications (overdose) or treatment failure (COVID-19).
- Opioid deaths primarily involve respiratory depression, while NSAIDs cause organ damage through chronic use.
Limitations
- Ivermectin data: Most mortality reports involve confounding factors (polypharmacy in scabies cases, COVID-19 severity in pandemic-era reports).
- Prescription drug data: Includes both proper use complications (e.g., NSAID GI bleeding) and misuse (e.g., opioid overdoses).
This comparison highlights that while ivermectin carries risks when misused, its mortality profile remains extremely limited compared to widely used medications with inherent toxicities at therapeutic doses.